# Role of Antioxidants (Vitamin C and E) in the Management of Schizophrenia

> **NCT04078048** · NA · COMPLETED · sponsor: **University of Health Sciences Lahore** · enrollment: 105 (actual)

## Conditions studied

- Schizophrenia

## Interventions

- **DIETARY_SUPPLEMENT:** Antioxidants (Vitamin C, E )

## Key facts

- **NCT ID:** NCT04078048
- **Lead sponsor:** University of Health Sciences Lahore
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-04-27
- **Primary completion:** 2017-08-11
- **Final completion:** 2017-11-15
- **Target enrollment:** 105 (ACTUAL)
- **Last updated:** 2019-09-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04078048

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04078048, "Role of Antioxidants (Vitamin C and E) in the Management of Schizophrenia". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04078048. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*